Story type: Discovery

A cell therapy could reduce inflammatory response in liver disease, offering hope to thousands of Australians suffering from the disease.…  Read more

A world-first study at Hudson Institute has taken a big step to understanding the causes of neonatal brain injury…  Read more

A colon cancer research breakthrough at Hudson Institute has shown that combining two types of drugs targeting gene expression stops cancer proliferation.…  Read more

Neural Stem Cells have strong potential to be effective in reducing brain injury in newborn babies, in the most extensive review of research on the topic.…  Read more

A promising early intervention treatment for cerebral palsy in newborn babies has proven effective in both boys and girls – even though it works differently depending on the sex of the offspring.…  Read more

RNA technology developed by Hudson Institute of Medical Research with the potential to limit inflammatory side-effects of RNA therapeutics such as mRNA vaccines, is the subject of a new licensing deal.…  Read more

Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.…  Read more

An anti-inflammatory drug that’s been widely used for decades may prove to be an ideal tool to help doctors prevent cerebral palsy in preterm babies.…  Read more

A study on how genes of the immune system influence the development of gastric (stomach) cancer has identified a key contributor, offering the potential for better prognosis and treatment of this deadly disease.…  Read more

Researchers looking into one of the deadliest forms of cancer have made a big breakthrough by drilling down to the molecular level.…  Read more